Robert Heft - Net Worth and Insider Trading

Robert Heft Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Robert Heft owns 2 companies in total, including Ra Pharmaceuticals Inc (RARX) , and Eloxx Pharmaceuticals Inc (ELOX) .

Click here to see the complete history of Robert Heft’s form 4 insider trades.

Insider Ownership Summary of Robert Heft

Ticker Comapny Transaction Date Type of Owner
RARX Ra Pharmaceuticals Inc 2020-04-02 director
ELOX Eloxx Pharmaceuticals Inc 2017-12-19 director

Robert Heft Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Robert Heft Ownership Network

Ownership Network List of Robert Heft

No Data

Ownership Network Relation of Robert Heft

Insider Network Chart

Robert Heft Owned Company Details

What does Ra Pharmaceuticals Inc do?

Who are the key executives at Ra Pharmaceuticals Inc?

Robert Heft is the director of Ra Pharmaceuticals Inc. Other key executives at Ra Pharmaceuticals Inc include Executive VP and CFO David Charles Lubner , director & 10 percent owner Rajeev M. Shah , and 10 percent owner New Enterprise Associates 13 Lp .

Ra Pharmaceuticals Inc (RARX) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Ra Pharmaceuticals Inc (RARX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Ra Pharmaceuticals Inc (RARX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Ra Pharmaceuticals Inc (RARX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Ra Pharmaceuticals Inc Insider Transactions

No Available Data

Robert Heft Mailing Address

Above is the net worth, insider trading, and ownership report for Robert Heft. You might contact Robert Heft via mailing address: 87 Cambridgepark Drive, C/o Ra Pharmaceuticals, Inc., Cambridge Ma 02140.

Discussions on Robert Heft

No discussions yet.